The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis
Top Cited Papers
- 24 July 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cellular and Molecular Life Sciences
- Vol. 70 (5), 795-814
- https://doi.org/10.1007/s00018-012-1080-8
Abstract
The mammalian genome is transcribed in a developmentally regulated manner, generating RNA strands ranging from long to short non-coding RNA (ncRNAs). NcRNAs generated by intergenic sequences and protein-coding loci, represent up to 98 % of the human transcriptome. Non-coding transcripts comprise short ncRNAs such as microRNAs, piwi-interacting RNAs, small nucleolar RNAs and long intergenic RNAs, most of which exercise a strictly controlled negative regulation of expression of protein-coding genes. In humans, the DLK1-DIO3 genomic region, located on human chromosome 14 (14q32) contains the paternally expressed imprinted genes DLK1, RTL1, and DIO3 and the maternally expressed imprinted genes MEG3 (Gtl2), MEG8 (RIAN), and antisense RTL1 (asRTL1). This region hosts, in addition to two long intergenic RNAs, the MEG3 and MEG8, one of the largest microRNA clusters in the genome, with 53 miRNAs in the forward strand and one (mir-1247) in the reverse strand. Many of these miRNAs are differentially expressed in several pathologic processes and various cancers. A better understanding of the pathophysiologic importance of the DLK1-DIO3 domain-containing microRNA cluster may contribute to innovative therapeutic strategies in a range of diseases. Here we present an in-depth review of this vital genomic region, and examine the role the microRNAs of this region may play in controlling tissue homeostasis and in the pathogenesis of some human diseases, mostly cancer, when aberrantly expressed. The potential clinical implications of this data are also discussed.Keywords
This publication has 135 references indexed in Scilit:
- MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpointJournal of Hepatology, 2011
- Silencing of the Imprinted DLK1-MEG3 Locus in Human Clinically Nonfunctioning Pituitary AdenomasThe American Journal of Pathology, 2011
- No-Nonsense Functions for Long Noncoding RNAsCell, 2011
- Inhibition of Anti-HIV MicroRNA Expression: A Mechanism for Opioid-Mediated Enhancement of HIV Infection of MonocytesThe American Journal of Pathology, 2011
- Long Noncoding RNAs with Enhancer-like Function in Human CellsCell, 2010
- CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysisGenes, Chromosomes and Cancer, 2009
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- Maternally imprinted microRNAs are differentially expressed during mouse and human lung developmentDevelopmental Dynamics, 2006
- Expression profiling identifies microRNA signature in pancreatic cancerInternational Journal of Cancer, 2006
- A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding HeteroduplexesCell, 2006